Brief: Edwards Lifesciences Announces CFO Transition Plan
30/10/2025 21:56
Oct 30 (Reuters) - Edwards Lifesciences Corp EW.N: EDWARDS LIFESCIENCES ANNOUNCES CFO TRANSITION PLAN EDWARDS LIFESCIENCES CORP: SCOTT ULLEM, COMPANY'S CHIEF FINANCIAL OFFICER, HAS DECIDED TO TRANSITION FROM HIS ROLE BY MIDYEAR 2026 Source text: ID:nBw9BSxXha Further company coverage: EW.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edwards Lifesciences
See all newsFDA flags Edwards heart-valve delivery system issue after death, injury (updated)
FDA flags Edwards heart-valve delivery system issue after death, injury
Brief: FDA Aware Edwards Lifesciences Issued Letter Recommending Some Delivery Systems Used For Sapien M3 Transcatheter Mitral Valve Replacement Be Removed
Brief: Edwards Lifesciences Corporation - Maintains Confidence In Financial Guidance For 2026
U.S. RESEARCH ROUNDUP-Deckers Brands, Rollins, United Rentals